POSC
Price
$1.75
Change
+$0.10 (+6.06%)
Updated
Aug 6 closing price
Capitalization
442.55K
RSMDF
Price
$16.66
Change
-$8.11 (-32.74%)
Updated
Aug 6 closing price
Capitalization
32.67B
77 days until earnings call
Interact to see
Advertisement

POSC vs RSMDF

Header iconPOSC vs RSMDF Comparison
Open Charts POSC vs RSMDFBanner chart's image
Positron
Price$1.75
Change+$0.10 (+6.06%)
Volume$9.69K
Capitalization442.55K
Resmed
Price$16.66
Change-$8.11 (-32.74%)
Volume$208
Capitalization32.67B
POSC vs RSMDF Comparison Chart in %
Loading...
POSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
POSC vs. RSMDF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POSC is a Hold and RSMDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (POSC: $1.75 vs. RSMDF: $16.66)
Brand notoriety: POSC and RSMDF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: POSC: 58% vs. RSMDF: 4%
Market capitalization -- POSC: $442.55K vs. RSMDF: $32.67B
POSC [@Medical Specialties] is valued at $442.55K. RSMDF’s [@Medical Specialties] market capitalization is $32.67B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

POSC’s FA Score shows that 1 FA rating(s) are green whileRSMDF’s FA Score has 1 green FA rating(s).

  • POSC’s FA Score: 1 green, 4 red.
  • RSMDF’s FA Score: 1 green, 4 red.
According to our system of comparison, both POSC and RSMDF are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

POSC’s TA Score shows that 5 TA indicator(s) are bullish while RSMDF’s TA Score has 3 bullish TA indicator(s).

  • POSC’s TA Score: 5 bullish, 5 bearish.
  • RSMDF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, POSC is a better buy in the short-term than RSMDF.

Price Growth

POSC (@Medical Specialties) experienced а -9.84% price change this week, while RSMDF (@Medical Specialties) price change was -32.58% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.65%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was -3.32%.

Reported Earning Dates

RSMDF is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical Specialties (+0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RSMDF($32.7B) has a higher market cap than POSC($443K). RSMDF has higher P/E ratio than POSC: RSMDF (37.59) vs POSC (0.09). POSC YTD gains are higher at: 73.267 vs. RSMDF (-26.927). RSMDF has higher annual earnings (EBITDA): 1.31B vs. POSC (-699K). RSMDF has more cash in the bank: 228M vs. POSC (28K). POSC has less debt than RSMDF: POSC (962K) vs RSMDF (1.72B). RSMDF has higher revenues than POSC: RSMDF (4.02B) vs POSC (1.24M).
POSCRSMDFPOSC / RSMDF
Capitalization443K32.7B0%
EBITDA-699K1.31B-0%
Gain YTD73.267-26.927-272%
P/E Ratio0.0937.590%
Revenue1.24M4.02B0%
Total Cash28K228M0%
Total Debt962K1.72B0%
FUNDAMENTALS RATINGS
POSC vs RSMDF: Fundamental Ratings
POSC
RSMDF
OUTLOOK RATING
1..100
1399
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
45100
SMR RATING
1..100
10037
PRICE GROWTH RATING
1..100
4842
P/E GROWTH RATING
1..100
10092
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSMDF's Valuation (13) in the null industry is in the same range as POSC (24). This means that RSMDF’s stock grew similarly to POSC’s over the last 12 months.

POSC's Profit vs Risk Rating (45) in the null industry is somewhat better than the same rating for RSMDF (100). This means that POSC’s stock grew somewhat faster than RSMDF’s over the last 12 months.

RSMDF's SMR Rating (37) in the null industry is somewhat better than the same rating for POSC (100). This means that RSMDF’s stock grew somewhat faster than POSC’s over the last 12 months.

RSMDF's Price Growth Rating (42) in the null industry is in the same range as POSC (48). This means that RSMDF’s stock grew similarly to POSC’s over the last 12 months.

RSMDF's P/E Growth Rating (92) in the null industry is in the same range as POSC (100). This means that RSMDF’s stock grew similarly to POSC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
POSCRSMDF
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
38%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
24%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
28%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
25%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
34%
Advances
ODDS (%)
Bullish Trend 15 days ago
69%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
33%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
POSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOMH5.600.17
+3.13%
Dominari Holdings
TTGT6.55-0.14
-2.09%
TechTarget
LUCK9.44-0.21
-2.18%
Lucky Strike Entertainment Corporation
TFX112.07-2.78
-2.42%
Teleflex
PTIX2.88-0.15
-5.11%
Protagenic Therapeutics Inc

POSC and

Correlation & Price change

A.I.dvisor tells us that POSC and SLDX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POSC and SLDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POSC
1D Price
Change %
POSC100%
+5.74%
SLDX - POSC
27%
Poorly correlated
-14.29%
GMED - POSC
20%
Poorly correlated
-1.51%
RSMDF - POSC
9%
Poorly correlated
-32.74%
RSCF - POSC
8%
Poorly correlated
N/A
PFGTF - POSC
7%
Poorly correlated
N/A
More

RSMDF and

Correlation & Price change

A.I.dvisor tells us that RSMDF and NAOV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSMDF and NAOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
-32.74%
NAOV - RSMDF
30%
Poorly correlated
-4.75%
RMD - RSMDF
20%
Poorly correlated
-1.59%
PFGTF - RSMDF
19%
Poorly correlated
N/A
POSC - RSMDF
9%
Poorly correlated
+5.74%
SAFLF - RSMDF
9%
Poorly correlated
N/A
More